Gene · 7939
NIH grants1,570
NIH grants whose papers are about the gene, through NIH's grant-paper links.
301 to 320 of 1,570
Download this page as JSON| Grant | Title | LAP papers | Newest fiscal year |
|---|---|---|---|
| ZIAHD001010 | Mechanism and Regulation of Eukaryotic Protein Synthesis | 1 | 2025 |
| ZICAI001052 | Infectious Diseases Collaborative Technological Research Resources- RML | 1 | 2025 |
| ZICBC011079 | Molecular Diagnostics Core Laboratory | 1 | 2025 |
| P20GM104316 | Discovery of Chemical Probes and Therapeutic Leads, Phase II | 9 | 2024 |
| U01DE029759 | Depleting exosomes to improve responses to immune therapy in HNSCC | 4 | 2024 |
| R01AR077362 | Engineered Developmental Microenvironments: Cartilage Formation and Maturation | 2 | 2024 |
| R01CA253615 | Bioprinting Plant Virus Nanoparticles for Immunotherapy and Relapse Prevention of Ovarian Cancer | 2 | 2024 |
| R01DE023926 | KSHV Epigenetic Regulation | 2 | 2024 |
| R01EB005807 | Physically Realistic Virtual Surgery | 2 | 2024 |
| R01HL153096 | Hybrid Hydrogel Biomaterials Comprising Clickable Decellularized Extracellular Matrix for Engineering Dynamic 3D Models of Fibrosis | 2 | 2024 |
| T32CA060397 | Postdoctoral Training in Head and Neck Oncology | 2 | 2024 |
| T32EB001026 | Cellular Approaches to Tissue Engineering and Regeneration | 2 | 2024 |
| ZIABC009392 | Determining the Fate of Transmembrane Proteins | 2 | 2024 |
| ZIABC010292 | Enzymes and Substrates of the Ubiquitin Conjugating System | 2 | 2024 |
| I01RX003375 | Knee Joint Resurfacing with Anatomic Tissue Engineered Osteochondral Implants | 1 | 2024 |
| IK2BX004097 | The Functional Role of Exosomes in Stem Cell Mediated Cardiac Repair | 1 | 2024 |
| K08AI148456 | Epigenetic regulation of esophageal epithelial barrier function in eosinophilic esophagitis | 1 | 2024 |
| K25HL148386 | Injectable Carbon Nanotube-Functionalized Hydrogel for miRNA Delivery | 1 | 2024 |
| P01AI057788 | Mechanisms of Norovirus Pathogenesis and Replication to Develop Therapeutics | 1 | 2024 |
| P01CA084203 | Photodynamic Priming of Cancer and Image-guidance for Optimal Immune Response | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7939/grants?page=16